The life sciences and health care industry are seeing an increased and more complex regulation of its activities and services. Payment of considerable research and development costs often presumes effectively obtaining and executing the rights related to the products and services being developed. New technologies allow the development of completely new products and services while increasing the risk that the existing business foundation is being disrupted. These and other factors pose great demands on the adaptability of the industry.

The life sciences team is composed in such a way that it allows us to offer our clients legal and strategic expert advice in the areas where the life sciences industry and investors need it.

Our size and industry experience allows us to provide legal advice for many pharmaceutical and biotech enterprises, medical device companies and venture funds and others who want to invest in or acquire life sciences enterprises.

The Life Sciences industry group includes lawyers with core competencies and long-standing experience within IP, regulatory issues, Corporate/M&A, competition law, procurement law and data privacy law.

Simonsen Vogt Wiig is co-founders of Oslo Life Science Forum.